All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Monoclonal Antibody Scholarly Open Access Journals
Some monoclonal antibodies are additionally immunotherapy since they help turn the safe framework against disease. For instance, some monoclonal antibodies mark disease cells with the goal that the insusceptible framework will better perceive and pulverize them. A model is rituximab, which ties to a protein called CD20 on B cells and a few sorts of malignant growth cells, making the safe framework murder them. B cells are a kind of white platelet. Other monoclonal antibodies bring T cells near malignancy cells, helping the invulnerable cells murder the disease cells. A model is blinatumomab (Blincyto®), which ties to both CD19, a protein found on the outside of leukemia cells, and CD3, a protein on the outside of T cells. This procedure enables the T cells to draw near enough to the leukemia cells to react to and murder them.